-
Scotland’s NHS could reimburse Vertex CF drugs, price row ongoing in England
pharmaphorum
December 21, 2018
Vertex is to file its two latest cystic fibrosis drugs with Scotland’s drug cost watchdog in a bid for NHS reimbursement – but an ongoing row over price in England is still unresolved.
-
NICE publishes updated guidance with expanded recommendation for Oncotype DX
pharmatimes
December 21, 2018
The National Institute for Health and Care Excellence (NICE) has announced the release of a second set of guidelines recommending three tests as options to help NHS clinicians decide whether
-
Nearly half of CCGs rated ‘requires improvement’ or ‘inadequate’
pharmatimes
December 20, 2018
A new report from the National Audit Office has found that in 2017/18, 42% (87 of 207) of Clinical Commissioning Groups (CCGs) were rated either ‘requires improvement’ or ‘inadequate’, with as little as 10% rated as ‘outstanding’.
-
NICE expands its recommendation for Oncotype Dx test
pharmaceutical-technology
December 20, 2018
The UK’s pricing regulator the National Institutes of Health and Care Excellence (NICE) has expanded its guidance for Genomic Health’s Oncotype Dx Breast Recurrence Score to include early lymph node (LN)-negative breast cancer......
-
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
pharmaphorum
December 19, 2018
NICE has said AbbVie’s Venclyxto (venetoclax), in combination with development partner Roche’s MabThera/Rituxan (rituximab), is not a cost-effective use of NHS resources as a treatment for a kind of leukaemia.
-
ConvaTec looks to support UK wound care through sector deal
pharmaphorum
December 18, 2018
Wound care specialist ConvaTec has welcomed the UK government’s Sector Deal for wound care and set out how it plans to support the country’s industry going forward.
-
No-deal Brexit stockpiling puts pressure on supply chain
pharmafile
December 18, 2018
The stockpiling of medicines in preparation for a no-deal Brexit is putting pressure on the supply chain and causing shortages of generic medicines, according to Simon Dukes, chief executive of the PSNC.
-
NHS overcrowding leads to ambulances being turned away
pharmafile
December 18, 2018
NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above 85% is unsafe.
-
All practices in England now offering extended GP access
pharmatimes
December 18, 2018
NHS England has announced that patients across England can now access GP appointments in the evening and weekends, resulting in as many as nine million extra appointments per year.
-
UK opens doors to cannabis-based therapies via NHS
pharmaphorum
December 17, 2018
Medical cannabis is available to certain patients across the UK for the first time from today.The groundbreaking decision was made so that .....